This chapter explores the operational challenges of scaling a telemedicine company from hundreds of thousands to millions in revenues. It emphasizes the significance of workforce training, communication with pharmacies, and the evolving landscape of compound pharmacies and peptides in promoting patient-centered care.
Ernest Colling, Founder & CEO of Transcend
-
From high school dropout to CEO. His history, background, and how he got into the peptide telemedicine space. (2:24)
-
The first surprises and opportunities starting a telemedicine company. (23:49)
-
His first introduction to peptides, and the most impactful ones to him. (28:30)
-
At what point did he know things were taking off? (34:52)
-
Scaling issues encountered. (36:50)
-
How do these compound pharmacies work? (38:12)
-
A better quality of life with preventative medicine. (39:59)
-
How has the cost for the end consumer changed? (42:19)
-
Does every peptide have a name brand? (44:05)
-
The motivation and meaning behind his foundation. (48:21)
-
How EMDR therapy changed his life. (53:27)
-
The importance and value of getting your blood work done to find your baseline. (54:51)
Related Links/Products Mentioned
Featured Guest/People Mentioned